Evaluation of effect of chemotherapy for depiction of metastatic liver tumor on gadoxetate disodium enhanced MRI
Not Applicable
- Conditions
- metastatic liver tumor
- Registration Number
- JPRN-UMIN000005401
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(a)Patients who are contraindicated in MRI examination (for example; patients with pace maker and claustrophobia patients). (b)Patients with history of severe side effect of gadolinium contrast media and gadoxetate disodium. (c)Patients with poor performance status. (d)Patients with bronchial asthma. (e)Patients with severe liver damage (Serum bilirubin > 2.0mg/dL). (f)Patients with severe kidney damage (eGFR < 30ml/min/1.73m2). (g)Gravid or lactating patients and patients who may be pregnant. (h)Patients whom their doctor decide to be inappropriate for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method